We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development a... Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development and commercialization of novel clean-surfaced nanotechnology therapeutics (Drugs, and (2) the development and commercialization of dietary supplements (Supplements). Show more
LOS ANGELES, March 19, 2024 (GLOBE NEWSWIRE) -- via IBN β IBN, a multifaceted communications organization engaged in connecting public companies with the investment community, today announces...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0026 | 0.789074355083 | 0.3295 | 0.359 | 0.3131 | 559110 | 0.3426654 | CS |
4 | -0.0991 | -22.9823747681 | 0.4312 | 0.46 | 0.304 | 1478107 | 0.33850454 | CS |
12 | -0.1351 | -28.9169520548 | 0.4672 | 0.5323 | 0.304 | 949918 | 0.38413987 | CS |
26 | -0.1029 | -23.6551724138 | 0.435 | 0.6 | 0.25 | 912535 | 0.37943669 | CS |
52 | -0.6043 | -64.5343870141 | 0.9364 | 1.09 | 0.25 | 678035 | 0.49891123 | CS |
156 | -9.5929 | -96.6539042821 | 9.925 | 17.82 | 0.25 | 543395 | 2.54202952 | CS |
260 | -9.5379 | -96.6352583587 | 9.87 | 17.82 | 0.25 | 512860 | 2.94765374 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions